[Pharmacological chaperones: a potential therapeutic treatment for conformational diseases]

Abstract : Many genetic and neurodegenerative diseases in humans result from protein misfolding and/or aggregation. These diseases are named conformational diseases. As a result, the misfolded non functional proteins are rejected and misrouted by the cellular quality control system, and cannot play their endogenous physiological roles. Specific compounds (ligands, substrates or inhibitors) known as pharmacological chaperones are able to bind and stabilize these misfolded proteins. Their interaction allows the target proteins to escape the quality control system and to be functionally rescued. These pharmacochaperones may possess different intrinsic activity: they can be antagonists (inhibitors), agonists (activators) or allosteric modulators of the target receptors, ionic channels or enzymes. Pharmacological chaperones have obviously a therapeutic potential to treat rare diseases like cystic fibrosis, retinitis pigmentosa, nephrogenic diabetes insipidus, Fabry disease, Gaucher disease, but also for cancers and more frequent and highly invalidant neurodegenerative disorders such as Alzheimer's disease or Parkinson's disease.
Type de document :
Article dans une revue
médecine/sciences, EDP Sciences, 2010, 26 (6-7), pp.627-35
Liste complète des métadonnées

Littérature citée [50 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00516358
Contributeur : Bernard Mouillac <>
Soumis le : vendredi 10 décembre 2010 - 09:28:48
Dernière modification le : jeudi 11 janvier 2018 - 06:19:40
Document(s) archivé(s) le : vendredi 11 mars 2011 - 02:21:37

Fichier

MSC-090397_-_fA_vrier2010.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

  • HAL Id : inserm-00516358, version 1
  • PUBMED : 20619166

Collections

Citation

Christiane Mendre, Bernard Mouillac. [Pharmacological chaperones: a potential therapeutic treatment for conformational diseases]. médecine/sciences, EDP Sciences, 2010, 26 (6-7), pp.627-35. 〈inserm-00516358〉

Partager

Métriques

Consultations de la notice

261

Téléchargements de fichiers

1228